Redox proteomics

Antioxidants and Redox Signaling

Volumn 17, Issue 11, 2012, Pages 1487-1489

  Allan Butterfield, D ^a   Dalle Donne, Isabella ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; ELECTROPHILE; ELECTROPHILE RESPONSIVE PROTEOME; LEUCINE RICH REPEAT KINASE 2; PROTEOME; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHRONIC KIDNEY DISEASE; FUNCTIONAL PROTEOMICS; HOMEOSTASIS; HUMAN; MASS SPECTROMETRY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRION; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL PROTEOMICS;

AGING; ALZHEIMER DISEASE; HUMANS; OXIDATION-REDUCTION; PARKINSON DISEASE; PROTEOMICS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 84866851264     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4742     Document Type: Review

References (9)

1. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes C, Robinson R, and Sultana R. Redox proteomics in selected neurodegenerative disorders. From its infancy to future applications. Antioxid Redox Signal 17: 1610-1655, 2012.
2. Butterfield DA, Poon HF, St. Clair D, Keller JN, Pierce WM, Klein JB, and Markesbery WR. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 22: 223-232, 2006.
3. Butterfield DA, Reed T, Newman SF, and Sultana R. Roles of amyloid b-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43: 658-677, 2007. (Pubitemid 47102132)
4. Butterfield DA and Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12: 61-72, 2007. (Pubitemid 47396301)
5. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, and Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 34: 85-96, 2009.
6. Dalle-Donne I, Scaloni A, and Butterfield DA. (Eds). Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Disease. Hoboken: John Wiley & Sons, Inc., 2006, p. 944.
7. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, Colombo R, Rossi R, and Milzani A. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 24: 55-99, 2005. (Pubitemid 40146422)
8. Giustarini D, Dalle-Donne I, Tsikas D, and Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46: 241-281, 2009.
9. Sultana R and Butterfield DA. Identification of the oxidative stress proteome in the brain. Free Radic Biol Med 50: 487-494, 2011.